Evidence map›Paper›PMID 38728587›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

A Tumor Environment-Activated Photosensitized Biomimetic Nanoplatform for Precise Photodynamic Immunotherapy of Colon Cancer.

Mengmeng Xiong, Ying Zhang, Huan Zhang, Qiaoqiao Shao, Qifan Hu, Junjie Ma, Yiqun Wan, Lan Guo, Xin Wan, Haitao Sun and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Constructing Activatable Photosensitizers Using Covalently Modified Mesoporous Silica.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mengmeng XiongSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, P. R. China.
Ying ZhangState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, 330047, P. R. China.
Huan ZhangSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, P. R. China.
Qiaoqiao ShaoState Key Laboratory of Precision Spectroscopy, School of Physics and Electronic Science, East China Normal University, Shanghai, 200241, P. R. China.
Qifan HuPostdoctoral Innovation Practice Base, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, P. R. China.
Junjie MaSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, P. R. China.
Yiqun WanSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, P. R. China.
Lan GuoSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, P. R. China.
Xin WanSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, P. R. China.
Haitao SunState Key Laboratory of Precision Spectroscopy, School of Physics and Electronic Science, East China Normal University, Shanghai, 200241, P. R. China.
Zhongyi YuanSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330031, P. R. China.
Hao WanState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, 330047, P. R. China.ORCID 0000-0002-9990-2359

Funding

National Natural Science Foundation of China 12274128National Natural Science Foundation of China 22379061National Natural Science Foundation of China 32101212National Natural Science Foundation of China 32372322Natural Science Foundation of Jiangxi Province 20224ACB215009Natural Science Foundation of Jiangxi Province 2023ACB205024Shanghai Rising-Star Program 21QA1402600
6 · The paper itself

Abstract

Aggressive nature of colon cancer and current imprecise therapeutic scenarios simulate the development of precise and effective treatment strategies. To achieve this, a tumor environment-activated photosensitized biomimetic nanoplatform (PEG

Indexed as

Colonic NeoplasmsImmunotherapyPhotochemotherapyPhotosensitizing AgentsAnimalsBiomimeticsCell Line, TumorDisease Models, AnimalMetal-Organic FrameworksMiceMice, Inbred BALB CNanoparticlesOligodeoxyribonucleotidesProgrammed Cell Death 1 ReceptorTumor MicroenvironmentCPG-oligonucleotideMetal-Organic FrameworksOligodeoxyribonucleotidesPhotosensitizing AgentsProgrammed Cell Death 1 Receptoranti‐tumor immune responsebiomimetic nanoplatformevasion of immune surveillancetumor environment‐activated photodynamic therapytumor targeting

Identifiers

PMID38728587
PMCPMC11267356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.